![Steven King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 291 996 $ in data 31/08/2026
Steven W.
King was the founder of Avid Bioservices, Inc., founded in 2001, where the titles held included President, Chief Executive Officer & Director from 2001 to 2017.
Mr. King is the founder of Mosaic ImmunoEngineering, Inc., founded in 2020, holding the titles of President, CEO, CFO & Director since 2020.
Current jobs include President, Chief Executive Officer & Director at Mosaic ImmunoEngineering Development Co., Director at Oncotelic Therapeutics, Inc. since 2020, and Director at Oncotelic, Inc. Former jobs included President, Chief Executive Officer & Director at Avid Bioservices, Inc. from 2011 to 2017, Chief Executive Officer at Edgepoint, Inc., and Director at Patriot Scientific Corp.
in 2020.
Education includes undergraduate and graduate degrees from Texas Tech University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2025 | 1.641.252 ( 22,66% ) | 188 744 $ | 31/08/2026 | |
| 12/04/2025 | 3.330.647 ( 0,73% ) | 103 250 $ | 31/08/2026 | |
| 21/08/2020 | 161.000 ( 25,56% ) | 2 $ | 31/08/2020 |
| Società | Posizione | Inizio |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 11/05/2020 |
| MOSAIC IMMUNOENGINEERING, INC. | Amministratore Delegato | 31/08/2020 |
Oncotelic, Inc.
 Oncotelic, Inc. BiotechnologyHealth Technology Develops RNA therapeutics and small molecule drugs targeting cancer and infectious diseases | Direttore/Membro del Consiglio | - |
Mosaic ImmunoEngineering Development Co.
 Mosaic ImmunoEngineering Development Co. BiotechnologyHealth Technology Develops novel immunotherapies to treat and prevent cancer and infectious diseases | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
| AVID BIOSERVICES, INC. | Amministratore Delegato | 27/11/2017 |
Edgepoint, Inc. | Amministratore Delegato | - |
| PATRIOT SCIENTIFIC CORPORATION | Amministratore Delegato | - |
Avid Bioservices, Inc. /Old/
 Avid Bioservices, Inc. /Old/ Medical/Nursing ServicesHealth Services Provides highly specialized cell cultures for biotechnology testing | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Avid Bioservices, Inc.
 Avid Bioservices, Inc. Pharmaceuticals: MajorHealth Technology Engages in the developing and manufacturing of biologics | Health Technology |
Patriot Scientific Corp.
 Patriot Scientific Corp. SemiconductorsElectronic Technology Develops microprocessors | Electronic Technology |
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Texas Tech University
 Texas Tech University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avid Bioservices, Inc. /Old/
Avid Bioservices, Inc. /Old/ Medical/Nursing ServicesHealth Services Provides highly specialized cell cultures for biotechnology testing | Health Services |
Edgepoint, Inc. | |
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Develops RNA therapeutics and small molecule drugs targeting cancer and infectious diseases | Health Technology |
Mosaic ImmunoEngineering Development Co.
Mosaic ImmunoEngineering Development Co. BiotechnologyHealth Technology Develops novel immunotherapies to treat and prevent cancer and infectious diseases | Health Technology |
Mosaic ImmunoEngineering, Inc.
 Mosaic ImmunoEngineering, Inc. BiotechnologyHealth Technology Develops immunotherapy pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
